CHLD
CHANGE OF OWNER RECEIVED FROM IB
25/12/2025
Voltar para busca
Dado oficial do USPTO
BIOMIMESYS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
26/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 42
Data de depósito
29/09/2014
Data de registro
30/08/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2023
Última transação
26/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
98
Localização do titular
FR
Examinador
MORENO,PAUL A
Unidade examinadora
L30
Localização atual
TMEG LAW OFFICE 103
Titulares e representantes
Titulares
NETRI
H. P. (pessoa física)
CELENYS
Representantes
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary productsmatrix for cell culture in the nature of cell growth media for growing cells for medical or clinical usefor injectable biological tissue fillers for medical and veterinary purposes in the field of scientific researchmedicine and tissue engineering; plasters for medical purposes; chemical preparations for pharmaceutical or medical purposesmatrix for cell culture in the nature of cell growth media for growing cells for medical or clinical usefor injectable biological tissue fillers for medical and veterinary purposes in the field of scientific researchmedicine and tissue engineering; amino acids for medical use; adhesive bands for medical purposes; bandages for dressings; biological preparations for medical and veterinary usebiological preparations for use in cell culture in the field of scientific researchmedicine and tissue engineering; stem cells for medical use and for veterinary use; chemical preparations for medicalpharmaceutical and veterinary usematrix for cell culture in the nature of cell growth media for growing cells for medical or clinical usefor injectable biological tissue fillers for medical and veterinary purposes in the field of scientific researchmedicine and tissue engineering; culture media for use in augmentation of bone and tissue for medical purposes; Culture media for medical usefor cultivating human cellsprimary and stem cells; biological tissue cultures for medical use; biological tissue cultures for veterinary use; Diagnostic preparations for medical purposesfor diseases detection; medicines for dental use; medicines for veterinary use; medicines for human medicine; chemical reagents for medical or veterinary use; hyaluronic acid and polylactic acid for pharmaceutical purposes
Classe 10
Surgicalmedicaldental and veterinary apparatus and instrumentsbone void filler consisting of synthetic materials; implants consisting of artificial materials; orthopedic bandages for jointsorthopedic support bandages; surgical sponges; artificial skin for surgical use
Classe 42
Evaluationsassessments and research in the fields of science and technology provided by engineersscientific research; research and development of new products for others; technical project study in the nature of chemical and biological project management servicesbiological and chemical research and analysis; chemical analysis; chemical research; chemistry consultation; quality control for others; testing of materials; scientific study and research in the fields of scientific research and tissue engineering; scientific laboratory services; biological research; bacteriological research; cosmetic research; technical research in the field of scientific research and tissue engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
30/08/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
31/10/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
18/12/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
14/11/2023
INPC
INVALIDATION PROCESSED
14/11/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/11/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/03/2023
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
10/03/2023
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
10/03/2023
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
10/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/03/2023
ES71
TEAS SECTION 71 RECEIVED
29/08/2022
E15R
TEAS SECTION 15 RECEIVED
29/08/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/08/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/11/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/10/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/11/2019
GPNX
NOTIFICATION PROCESSED BY IB
16/06/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/12/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/12/2016
FIMP
FINAL DISPOSITION PROCESSED
01/12/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/11/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
30/08/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/07/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/06/2016
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/06/2016
PUBO
PUBLISHED FOR OPPOSITION
14/06/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/05/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/05/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/05/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/04/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
28/04/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/04/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
28/04/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/04/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/04/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/03/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
29/03/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/03/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
29/03/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/03/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/08/2015
GNFR
FINAL REFUSAL E-MAILED
27/08/2015
CNFR
FINAL REFUSAL WRITTEN
27/08/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/07/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/07/2015
ALIE
ASSIGNED TO LIE
20/07/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2015
RFNT
REFUSAL PROCESSED BY IB
27/02/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/02/2015
RFRR
REFUSAL PROCESSED BY MPU
11/02/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2015
CNRT
NON-FINAL ACTION WRITTEN
09/02/2015
MAFR
APPLICATION FILING RECEIPT MAILED
27/01/2015
DOCK
ASSIGNED TO EXAMINER
23/01/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/01/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/01/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOMIMESYS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.